Key result
The provided text contains only the journal's editorial board information and no clinical study data.
Why the study?
What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
This paper reviews the implications of the RE-LY, AVERROES, and ROCKET-AF trials for stroke prevention in patients with atrial fibrillation.
Editorial listing yields no evidence for AF stroke prevention; leaves open interpretation of RE-LY, AVERROES, ROCKET-AF trials.
No takes yet. Share an insight, caveat, or question.
Lip et al. (2011) conducted an editorial in atrial fibrillation. The provided text contains only the journal's editorial board information and no clinical study data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: